Equip EHV 1,4 Injection
This is a temperature sensitive item, please select the chilled next day delivery option at check out.Ā
Ā
For the active immunisation of horses and ponies to reduce the incidence of respiratory disease and viral shedding caused by infection with equine herpes virus types 1 and 4 (EHV-1 and EHV-4) and to reduce the incidence of abortion caused by infection with EHV-1. After completion of the primary vaccination course, the presence of antibodies has been demonstrated within 2 weeks and protection against virulent challenge has been demonstrated within 3 weeks. The duration of immunity is 6 months.
Ā
Ā
The vaccine has to be stored and transported in its original unopened undamaged packing in the dark at +2Ā°C - +8Ā°C. Exposure to heat and/or direct sunlight has to be avoided. Do not freeze.
Legal category
POM-V
Equip EHV 1,4 Injection
This is a temperature sensitive item, please select the chilled next day delivery option at check out.Ā
Ā
For the active immunisation of horses and ponies to reduce the incidence of respiratory disease and viral shedding caused by infection with equine herpes virus types 1 and 4 (EHV-1 and EHV-4) and to reduce the incidence of abortion caused by infection with EHV-1. After completion of the primary vaccination course, the presence of antibodies has been demonstrated within 2 weeks and protection against virulent challenge has been demonstrated within 3 weeks. The duration of immunity is 6 months.
Ā
Ā
The vaccine has to be stored and transported in its original unopened undamaged packing in the dark at +2Ā°C - +8Ā°C. Exposure to heat and/or direct sunlight has to be avoided. Do not freeze.
Legal category
POM-V
Product Information
Product Information
Shipping & Returns
Shipping & Returns
Description
This is a temperature sensitive item, please select the chilled next day delivery option at check out.Ā
Ā
For the active immunisation of horses and ponies to reduce the incidence of respiratory disease and viral shedding caused by infection with equine herpes virus types 1 and 4 (EHV-1 and EHV-4) and to reduce the incidence of abortion caused by infection with EHV-1. After completion of the primary vaccination course, the presence of antibodies has been demonstrated within 2 weeks and protection against virulent challenge has been demonstrated within 3 weeks. The duration of immunity is 6 months.
Ā
Ā
The vaccine has to be stored and transported in its original unopened undamaged packing in the dark at +2Ā°C - +8Ā°C. Exposure to heat and/or direct sunlight has to be avoided. Do not freeze.
Legal category
POM-V
